Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
Conditions
Interventions
Intervention1: Intracavitary Brachytherapy Applicator: indigenously designed applicator made up of poly phenyl sulfone or equivalent material will be used after proper sterilization for intracavitary
Sponsors
Department of Radiotherapy Radiation Medicine
Eligibility
Inclusion criteria
Inclusion criteria: 1.Histo-pathologically confirmed patients of carcinoma of the uterine cervix 2. FIGO stage IB2 to stage IVA 3. Patients who will give approved informed consent
Exclusion criteria
Exclusion criteria: 1.FIGO stage IVA with Vesicovaginal or recto-vaginal fistula and IVB cervical cancer 2.Previous history of pelvic irradiation 3.Post hysterectomy carcinoma cervix cases 4.Patients not completed planned treatment schedules Pregnant women or lactating mothers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We expect that as compare to commercially available applicator our applicator will have zero perforation, No artifacts on CT imaging. We Will evaluate the outcome in terms of toxicity and response. Timepoint: One year after completion of treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| NATimepoint: NA | — |
Countries
India
Contacts
Public ContactAnkur Mourya
Banaras Hindu University, Varanasi
Outcome results
None listed